Change in body weight and risk of #hypertension after switching from efavirenz to dolutegravir in adults with #HIV
Patients gained more weight and had higher risk of hypertension after switching from efavirenz to dolutegravir https://t.co/38Adx26Zs2 pic.twitter.com/I70uDLnUqv
— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) February 16, 2023
Discovered on: 2023-02-16 09:04:12
Source: @eClinicalMed: Change in body weight and risk of #hypertension after switch…